Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-19

Clinical Trial Update: Single and Multiple Dose Study in Japanese [Phase 1]

View source ↗

Summary

A Phase 1 single and multiple dose study conducted in Japanese subjects for gout has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED